Cargando…

When and how NK cell-induced programmed cell death benefits immunological protection against intracellular pathogen infection

NK cells are innate lymphoid cells that exert a key role in immune surveillance through the recognition and elimination of transformed cells and viral, bacterial, and protozoan pathogen-infected cells without prior sensitization. Elucidating when and how NK cell-induced intracellular microbial cell...

Descripción completa

Detalles Bibliográficos
Autores principales:	Belizário, José E, Neyra, Jennifer M, Setúbal Destro Rodrigues, Maria Fernanda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6830868/ https://www.ncbi.nlm.nih.gov/pubmed/30236030 http://dx.doi.org/10.1177/1753425918800200

Ejemplares similares

Checkpoint inhibitor blockade and epigenetic reprogrammability in CD8(+) T-cell activation and exhaustion
por: Belizário, José, et al.
Publicado: (2020)

NK Cell-Mediated Regulation of Protective Memory Responses against Intracellular Ehrlichial Pathogens
por: Habib, Samar, et al.
Publicado: (2016)

Mechanisms involved in cancer stem cell resistance in head and neck squamous cell carcinoma
por: Siqueira, Juliana Mota, et al.
Publicado: (2023)

Editorial: NK cells in viral immunology and immunotherapy
por: Mulik, Sachin, et al.
Publicado: (2023)

How single-cell immunology is benefiting from microfluidic technologies
por: Jammes, Fabien C., et al.
Publicado: (2020)

Mechanisms of immune evasion by head and neck cancer stem cells
por: Xavier, Flávia Caló Aquino, et al.
Publicado: (2022)

Syntaxin 11 marks a distinct intracellular compartment recruited to the immunological synapse of NK cells to colocalize with cytotoxic granules
por: Dabrazhynetskaya, Alena, et al.
Publicado: (2012)

Effects of Cetuximab and Erlotinib on the behaviour of cancer stem cells in head and neck squamous cell carcinoma
por: Setúbal Destro Rodrigues, Maria Fernanda, et al.
Publicado: (2018)

The Stem Cell Marker Bmi-1 Is Sensitive in Identifying Early Lesions of Carcinoma ex Pleomorphic Adenoma
por: Sedassari, Bruno Tavares, et al.
Publicado: (2015)

Intracellular immunity: finding the enemy within—how cells recognize and respond to intracellular pathogens
por: Tam, Jerry C. H., et al.
Publicado: (2014)

Immunological and Translational Aspects of NK Cell-Based Antitumor Immunotherapies
por: Shevtsov, Maxim, et al.
Publicado: (2016)

NK and T Cell Immunological Signatures in Hospitalized Patients with COVID-19
por: Bergantini, Laura, et al.
Publicado: (2021)

How Viral and Intracellular Bacterial Pathogens Reprogram the Metabolism of Host Cells to Allow Their Intracellular Replication
por: Eisenreich, Wolfgang, et al.
Publicado: (2019)

Failure of immunological competence: when to suspect?
por: Pinto-Mariz, Fernanda
Publicado: (2020)

How melanoma cells inactivate NK cells
por: Pietra, Gabriella, et al.
Publicado: (2012)

How to outsmart NK cell tolerance
por: Terszowski, Grzegorz, et al.
Publicado: (2015)

Cell death in sepsis: a matter of how, when, and where
por: Bantel, Heike, et al.
Publicado: (2009)

The role of photobiomodulation when associated with microneedling in female pattern hair loss: A randomized, double blind, parallel group, three arm, clinical study protocol
por: da Silveira, Suzana Polonca, et al.
Publicado: (2019)

Immunological Drivers in Graves' Disease: NK Cells as a Master Switcher
por: Gallo, Daniela, et al.
Publicado: (2020)

Influenza Vaccine Induces Intracellular Immune Memory of Human NK Cells
por: Dou, Yaling, et al.
Publicado: (2015)

NK Cells in Autoimmune Diseases: Protective or Pathogenic?
por: Liu, Meifang, et al.
Publicado: (2021)

Inhibitory Receptor Signaling Destabilizes Immunological Synapse Formation in Primary NK Cells
por: Abeyweera, Thushara P., et al.
Publicado: (2013)

Deciphering the Immunological Phenomenon of Adaptive Natural Killer (NK) Cells and Cytomegalovirus (CMV)
por: Barnes, Samantha, et al.
Publicado: (2020)

Evaluation of Immunological Parameters in Pregnant Women: Low Levels of B and NK Cells
por: de Carvalho Schettini, Juliana Araújo, et al.
Publicado: (2019)

How we treat NK/T-cell lymphomas
por: Tse, Eric, et al.
Publicado: (2022)

Immunological consequences of kidney cell death
por: Sarhan, Maysa, et al.
Publicado: (2018)

Immunology of Cell Death in Cancer Immunotherapy
por: Galluzzi, Lorenzo, et al.
Publicado: (2021)

Immunology of cell death in cancer and infection
por: Garg, Abhishek D.
Publicado: (2022)

Molecular pathogenic pathways in extranodal NK/T cell lymphoma
por: de Mel, Sanjay, et al.
Publicado: (2019)

Regulation of the human NK cell compartment by pathogens and vaccines
por: Goodier, Martin R, et al.
Publicado: (2021)

Leishmania major drives host phagocyte death and cell-to-cell transfer depending on intracellular pathogen proliferation rate
por: Baars, Iris, et al.
Publicado: (2023)

When breast cancer cells start to fend the educational process of NK cells off
por: Mamessier, Emilie, et al.
Publicado: (2013)

Increased expression of programmed cell death protein 1 on NK cells inhibits NK-cell-mediated anti-tumor function and indicates poor prognosis in digestive cancers
por: Liu, Y, et al.
Publicado: (2017)

Breast cancer immunology and immunotherapy: targeting the programmed cell death protein-1/programmed cell death protein ligand-1
por: Zhao, Jing, et al.
Publicado: (2020)

Necroptotic Cell Death Signaling and Execution Pathway: Lessons from Knockout Mice
por: Belizário, José, et al.
Publicado: (2015)

Funerals and Feasts: The Immunological Rites of Cell Death
por: Galimberti, Veronica E., et al.
Publicado: (2019)

Involvement of Activating NK Cell Receptors and Their Modulation in Pathogen Immunity
por: Marras, Francesco, et al.
Publicado: (2011)

Memory and Memory-Like NK Cell Responses to Microbial Pathogens
por: Brillantes, Marc, et al.
Publicado: (2020)

Programmed cell death 1‐expressing CD56‐negative natural killer (NK) cell expansion is a hallmark of chronic NK cell activation during dasatinib treatment
por: Ishiyama, Ken‐ichi, et al.
Publicado: (2020)

Corrigendum: Breast cancer immunology and immunotherapy: targeting the programmed cell death protein-1/programmed cell death protein ligand-1
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rn4cso5dedrkgkt9rpi830jnrl